1887

Abstract

The terminal portion of the herpes simplex virus (HSV) genome long repeat region has been shown to contain a neurovirulence gene. Both HSV-1 and HSV-2 mutants deleted in this gene fail to cause central nervous system (CNS) disease in mice. The HSV-1 strain 17 variant 1716, which has a 759 bp deletion encompassing the gene, grows normally in tissue culture but fails to grow following intracerebral inoculation of mice. This paper demonstrates that 1716 is capable of peripheral replication in the footpads of mice. However, no acute replication of virus is detectable in dorsal root ganglia up to 10 days after footpad inoculation. These results imply that the replication defect in 1716 is not host-specific, but is tissue- and/or cell type-specific. Latency reactivation kinetics demonstrate that 1716 is capable of establishing a latent infection, but the kinetics of reactivation are significantly impaired compared to wild-type virus and are dose-dependent. Lack of acute ganglionic replication combined with impaired reactivation kinetics support the conclusion that a proportion of 1716 genomes initiate a lytic infection which then aborts, and a proportion enter the latent state. The results with 1716 imply that its inability to replicate in CNS and peripheral nervous system neurons is specific, and that the block in replication is beyond the stage of adsorption and entry. A prerequisite for any live attenuated HSV vaccine is an inability to initiate CNS involvement following peripheral inoculation. In this respect, 1716 has prototype vaccine potential with the proviso that a direct extrapolation is being made from mouse to man.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-73-4-967
1992-04-01
2021-10-17
Loading full text...

Full text loading...

/deliver/fulltext/jgv/73/4/JV0730040967.html?itemId=/content/journal/jgv/10.1099/0022-1317-73-4-967&mimeType=html&fmt=ahah

References

  1. Ackermann M., Chou J., Sarmiento M., Lerner R. A., Roizman B. 1986; Identification by antibody to a synthetic peptide of a protein specified by a diploid gene located in the terminal repeats of the L component of herpes simplex virus genome. Journal of Virology 58:843–850
    [Google Scholar]
  2. Chou J., Roizman B. 1986; The terminal ‘a’ sequence of the herpes simplex virus genome contains the promoter of a gene located in the repeat sequences of the L component. Journal of Virology 57:629–637
    [Google Scholar]
  3. Chou J., Roizman B. 1990; The herpes simplex virus 1 gene for ICP34.5 which maps in inverted repeats is conserved in several limited passage isolates but not in strain 17 syn+ . Journal of Virology 64:1014–1020
    [Google Scholar]
  4. Dolan A., McKie E., MacLean A. R., McGeoch D. J. 1992; Status of the ICP34.5 gene in herpes simplex virus type 1 strain 17. Journal of General Virology 73:971–973
    [Google Scholar]
  5. McGeoch D. J., Cunningham C., McIntyre G., Dolan A. 1991; Comparative sequence analysis of the long repeat regions and adjoining parts of the long unique regions in the genomes of herpes simplex viruses types 1 and 2. Journal of General Virology 72:3057–3075
    [Google Scholar]
  6. Maclean A. R., Fareed M. U., Robertson L., Harland J., Brown S. M. 1991; Herpes simplex virus type 1 deletion variants 1714 and 1716 pinpoint neurovirulence-related sequences in Glasgow strain 17+ between immediate early gene 1 and the ‘a’ sequence. Journal of General Virology 72:631–639
    [Google Scholar]
  7. Mitchell W. J., Steiner L., Brown S. M., MacLean A. R., Subak-Sharpe J. H., Fraser N. W. 1990; A herpes simplex virus type 1 variant, deleted in the promoter region of the latency-associated transcripts, does not produce any detectable minor RNA species during latency in the mouse trigeminal ganglion. Journal of General Virology 71:953–957
    [Google Scholar]
  8. Steiner I., Spivack J. G., Lirette R. P., Brown S. M., MacLean A. R., Subak-Sharpe J. H., Fraser N. W. 1989; Herpes simplex virus latency associated transcripts are evidently not essential for latent infection. EMBO Journal 8:505–511
    [Google Scholar]
  9. Steiner I., Spivack J. G., Deshmane S. L., Ace C. L., Preston C. M., Fraser N. W. 1990; A herpes simplex virus type 1 mutant containing a non-transinducing Vmw65 protein establishes latent infection in vivo in the absence of viral replication and reactivates efficiently from explanted trigeminal ganglia. Journal of Virology 64:1630–1638
    [Google Scholar]
  10. Taha M. Y., Clements G. B., Brown S. M. 1989a; A variant of herpes simplex virus type 2 strain HG52 with a 1.5 kb deletion in RL between 0 to 0.02 and 0.81 to 0.83 map units is non-neurovirulent for mice. Journal of General Virology 70:705–716
    [Google Scholar]
  11. Taha M. Y., Clements G. B., Brown S. M. 1989b; The herpes simplex virus type 2 (HG52) variant JH2604 has a 1488 bp deletion which eliminates neurovirulence in mice. Journal of General Virology 70:3073–3078
    [Google Scholar]
  12. Taha M. Y., Brown S. M., Clements G. B., Graham D. I. 1990; The JH2604 deletion variant of herpes simplex virus type 2 (HG52) fails to produce necrotizing encephalitis following intracranial inoculation of mice. Journal of General Virology 71:1597–1601
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-73-4-967
Loading
/content/journal/jgv/10.1099/0022-1317-73-4-967
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error